pharma

Govt agencies, non-govt organisations collaborate on non-animal methodologies workshop

Read more

Asahi Kasei Pharma enters into exclusive license agreement for anti-CX3CR1 Antibody

Read more

Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030

Read more

Arvinas and Pfizer announce initial Phase 1b Data from the TACTIVE-U sub-study of Vepdegestrant in combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium

Read more

Syngene announces winners of the annual science quiz ‘Synquizitive’

Read more

PCRM survey shows that most Americans don’t prefer new weight-loss drugs

Read more

ENTOD Pharmaceuticals appoints Dr Anish Desai as Scientific & Research adviser

Read more

Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001

Read more

Biocon receives EIR with VAI status

Read more

Cobenfy could break dopamine dominance in schizophrenia treatment: GlobalData

Read more